ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for cancer patients in the United States. The company’s lead product candidate is Evorpacept, a ...
About ALX Oncology Holdings Inc. ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
1 Day ALXO -2.86% DJIA 0.60% Russell 2K 0.27% Health Care/Life Sciences -0.33% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results